GlassScriptPhysician profile
Matthew J Lynch
NPI 1609834704
$1,370.42
in general payments reported to CMS, 2019-2025
15 companies · $451 in 2025
The $451 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $111 · 2021: $113 · 2022: $36.41 · 2023: $117 · 2024: $411 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768 · Long Term Medical Supply Or Device Loan: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.00 |
| Long Term Medical Supply Or Device Loan | $211.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $297.63 | 2023-2025 | |
| Integra Lifesciences Corporation | $225.85 | 2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Dilon Technologies, INC. | $162.61 | 2024 | Hemoblast Bellows |
| Sientra, INC. | $120.37 | 2021-2022 | |
| Davol INC. | $109.51 | 2025 | Phasix Mesh |
| Mentor Worldwide LLC | $103.72 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $64.68 | 2019-2020 | |
| Motiva USA, LLC | $56.12 | 2025 | |
| Tela Bio, INC. | $46.65 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Tepha INC | $42.28 | 2019-2020 | |
| Kci USA, INC. | $34.59 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $31.93 | 2019-2024 | |
| Axogen | $31.58 | 2019 | |
| Revance Therapeutics, INC. | $29.45 | 2025 | Daxxify |
| Elutia, INC. | $13.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.